Incyte's top three insider shareholders as of May 04, 2026 are Bros. Advisors Lp Baker (Director, 28.19Mn shares), Bros. Advisors Lp Baker (Director, 28.19Mn shares), Bros. Advisors Lp Baker (Director, 28.19Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Bros. Advisors Lp Baker | - | 0 | 28,188,718 | 02 Apr, 2026 |
| Bros. Advisors Lp Baker | - | 0 | 28,188,718 | 02 Apr, 2026 |
| Bros. Advisors Lp Baker | - | 0 | 28,188,718 | 02 Apr, 2026 |
| Bros. Advisors Lp Baker | - | 0 | 28,188,718 | 02 Apr, 2026 |
| Herve Hoppenot | Special Advisor To The Ceo | 326,803 | 0 | 10 Dec, 2025 |
| Pablo J Cagnoni | President, Global Head Of Rd | 262,692 | 0 | 21 Apr, 2026 |
| William Meury | Chief Executive Officer | 161,101 | 0 | 17 Apr, 2026 |
| Christiana Stamoulis | Evp Chief Financial Officer | 125,759 | 0 | 16 Jul, 2025 |
| Paula J Swain | Evp, Human Resources | 106,482 | 0 | 16 Jul, 2025 |
| Paula J Swain | Evp, Human Resources | 106,482 | 0 | 16 Jul, 2025 |
| Yao Wenqing | Evp, Head Of Discovery Chem | 98,575 | 0 | 07 Jul, 2021 |
| Yao Wenqing | Evp, Head Of Discovery Chem | 98,575 | 0 | 07 Jul, 2021 |
| Steven H Stein | Cmo Head Of Late Stage Dev. | 73,252 | 0 | 17 Apr, 2026 |
| Maria E Pasquale | Evp General Counsel | 69,724 | 0 | 18 Jul, 2023 |
| Maria E Pasquale | Evp General Counsel | 69,724 | 0 | 18 Jul, 2023 |
| Mohamed Khairie Issa | Evp, Head Of Us Oncology | 66,132 | 0 | 08 Jan, 2026 |
| Mohamed Khairie Issa | Evp, Head Of Us Oncology | 66,132 | 0 | 08 Jan, 2026 |
| Patrick A Mayes | Evp Chief Scientific Officer | 60,011 | 0 | 12 Dec, 2025 |
| Patrick A Mayes | Evp Chief Scientific Officer | 60,011 | 0 | 12 Dec, 2025 |
| Dashyant Dhanak | Evp Chief Scientific Officer | 58,968 | 0 | 18 Jul, 2023 |
| Vijay K Iyengar | Evp, Gmapps | 40,540 | 0 | 17 Jul, 2025 |
| Vijay K Iyengar | Evp, Gmapps | 40,540 | 0 | 17 Jul, 2025 |
| Lee Heeson | Evp, Head Of Incyte Intl | 38,041 | 0 | 04 Feb, 2026 |
| Jonathan Elliott Dickinson | Evp, General Manager, Europe | 36,390 | 0 | 16 Sep, 2024 |
| Barry P Flannelly | Evp General Manager Us | 35,149 | 0 | 17 Jul, 2025 |
| Michael James Morrissey | Evp, Head Of Tech. Operations | 34,065 | 0 | 04 Feb, 2026 |
| Michael James Morrissey | Evp, Head Of Tech. Operations | 34,065 | 0 | 04 Feb, 2026 |
| Paul Trower | Principal Accounting Officer | 32,268 | 0 | 05 Jan, 2022 |
| Paul Trower | Principal Accounting Officer | 32,268 | 0 | 05 Jan, 2022 |
| Sheila A. Denton | Evp General Counsel | 26,569 | 0 | 19 Nov, 2025 |
| Paul J Clancy | - | 23,741 | 0 | 02 Apr, 2026 |
| Thomas Tray | Principal Accounting Officer | 22,973 | 0 | 22 Dec, 2025 |
| Thomas Tray | Principal Accounting Officer | 22,973 | 0 | 22 Dec, 2025 |
| Edmund Harrigan | - | 21,122 | 0 | 02 Apr, 2026 |
| Jean Jacques Bienaime | - | 20,841 | 0 | 12 Jun, 2025 |
| Jacqualyn A Fouse | - | 19,326 | 0 | 12 Jun, 2025 |
| Wendy L Dixon | - | 17,768 | 0 | 04 Apr, 2022 |
| Matteo Trotta | Evp, Gm, Dermatology Us | 14,882 | 0 | 26 Mar, 2026 |
| Matteo Trotta | Evp, Gm, Dermatology Us | 14,882 | 0 | 26 Mar, 2026 |
| Katherine A High | - | 13,341 | 0 | 12 Jun, 2025 |
| Otis W Brawley | - | 11,252 | 0 | 12 Jun, 2025 |
| Richard A. Hoffman | Evp General Counsel | 9,466 | 0 | 03 Dec, 2025 |
| David H Gardner | Evp, Chief Strategy Officer | 9,429 | 0 | 24 Sep, 2025 |
| Susanne Schaffert | - | 7,389 | 0 | 12 Jun, 2025 |
| Susanne Schaffert | - | 7,389 | 0 | 12 Jun, 2025 |
| Ramitpal K Basi | Evp, Human Resources | 6,506 | 0 | 27 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Apr, 2026 | Pablo J Cagnoni | Common Stock | A | 6,077 | $64.25 | 268,769 | D | M |
| 17 Apr, 2026 | Pablo J Cagnoni | Common Stock | A | 12,590 | $71.93 | 281,359 | D | M |
| 17 Apr, 2026 | Pablo J Cagnoni | Common Stock | D | 18,667 | $96.50 | 262,692 | D | S |
| 17 Apr, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 6,077 | $0.00 | 26,833 | D | M |
| 17 Apr, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 12,590 | $0.00 | 27,699 | D | M |
| 15 Apr, 2026 | Pablo J Cagnoni | Common Stock | A | 27,892 | $0.00 | 262,692 | D | A |
| 15 Apr, 2026 | Steven H Stein | Common Stock | A | 39,049 | $0.00 | 73,252 | D | A |
| 15 Apr, 2026 | William Meury | Common Stock | A | 125,000 | $0.00 | 161,101 | D | M |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 2,818,039 | I | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 2,818,039 | I | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 2,818,039 | I | A |
| 31 Mar, 2026 | Edmund Harrigan | Common Stock | A | 269 | $94.12 | 21,122 | D | A |
| 31 Mar, 2026 | Paul J Clancy | Common Stock | A | 265 | $94.12 | 23,741 | D | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 28,188,718 | I | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 28,188,718 | I | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 28,188,718 | I | A |
| 25 Mar, 2026 | Matteo Trotta | Common Stock | D | 537 | $92.23 | 14,882 | D | F |
| 25 Mar, 2026 | Matteo Trotta | Common Stock | D | 537 | $92.23 | 14,882 | D | F |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | A | 7,166 | $61.18 | 241,966 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | A | 11,501 | $64.25 | 253,467 | D | M |